Homodihydrocapsaicin I

CAS No. 20279-06-5

Homodihydrocapsaicin I ( —— )

Catalog No. M29165 CAS No. 20279-06-5

Homodihydrocapsaicin I is a natural product from Capsicum annuum L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 205 Get Quote
10MG 340 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Homodihydrocapsaicin I
  • Note
    Research use only, not for human use.
  • Brief Description
    Homodihydrocapsaicin I is a natural product from Capsicum annuum L.
  • Description
    Homodihydrocapsaicin I is a natural product from Capsicum annuum L.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20279-06-5
  • Formula Weight
    321.5
  • Molecular Formula
    C19H31NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(CNC(=O)CCCCCCCC(C)C)ccc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fibrinopeptide A, hu...

    Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.

  • 9,11-Dehydro-beta-bo...

    9,11-Dehydro-β-boswellic acid has urease inhibitory activity. 9,11-Dehydro-beta-boswellic acid inhibiting the key enzyme of leukotriene biosynthesis, 5-lipoxygenase (5-LO).

  • PSA1 141-150

    This Prostate Specific Antigen 1 peptide was used in the immunotherapy of cancer experiments.